Kostenreduktion im Krankenhaus – Transfusionswesen: Kann die Behandlung der präoperativen Anämie Kosten reduzieren?

Zusammenfassung

Die präoperative Anämie ist ein unabhängiger Risikofaktor in der operativen Medizin. Die präoperative Anämie ist mit höheren Behandlungskosten verbunden und der Hauptrisikofaktor für die Gabe von Bluttransfusionen. Die Transfusion von Erythrozytenkonzentraten ist, wenn auch bei akuter Anämie lebensrettend, in der operative Medizin ebenfalls mit erhöhter Mortalität, Morbidität und Komplikationen nach Operationen assoziiert. Für die präoperative Behandlung der Anämie wurden eine Verbesserung des postoperativen Outcome der Patienten und ein reduzierter Transfusionsbedarf gezeigt. Die Anämiebehandlung als eine Säule des Patient-Blood-Management hat durch Reduktion von Komplikationen und transfusionsassoziierter Morbidität das Potential, Kosten im Gesundheitswesen zu senken. Das ökonomische Potential der präoperativen Anämiebehandlung gegenüber den Kosten der Transfusion von Blutprodukten muss in prospektiven Studien untersucht werden.

Abstract

Preoprative Anaemia is an independent risk factor in perioperative medicine. Furthermore, preoperative anaemia is associated with higher treatment costs and remains the main risk factor for the transfusion of packed red blood cells. However, transfusion of packed red blood cells is although life-saving in conditions of acute anaemia associated with higher mortality, morbidity and postoperative complications. The preoperative treatment of anaemia has been shown to improve postoperative outcome and transfusion requirements. Treatment of anemia as one pillar of patient blood management bears the potential to reduce costs to the national health system by prevention of complications and transfusion-associated morbidity. The economic impact of the treatment of preoperative anaemia versus the treatment with blood products requires prospective evaluation.

Kernaussagen

• Die WHO definiert die Kriterien einer Anämie wie folgt:

  • Hb-Wert bei Männern < 13 g/dl

  • Hb-Wert bei nicht schwangeren Frauen < 12 g/dl

• Die präoperative Anämie ist ein signifikanter Risikofaktor für den postoperativen Heilungsverlauf und das Überleben der Patienten. Sie ist mit hohen Behandlungskosten verbunden und gilt als Hauptrisikofaktor für die Gabe von Bluttransfusionen.

• In den nächsten 20 Jahren wird Prognosen zufolge immer weniger Blut gespendet – der Bedarf an Erythrozytenkonzentraten wird hingegen steigen.

• Bluttransfusionen sind mit erhöhter postoperativer Mortalität, Morbidität und Komplikationen assoziiert.

• Die Behandlung der präoperativen Anämie ist nicht nur aus medizinischer, sondern auch aus betriebswirtschaftlicher Sicht sinnvoll, da somit Bluttransfusionen verhindert und Kosten sowie Komplikationen reduziert werden können.

Schlüsselwörter:

Anämie - präoperativ - Operation - Mortalität - Bluttransfusion

Keywords:

blood transfusion - anaemia - preoperative - mortality - surgery

• Literatur

• 1 Greinacher A, Fendrich K, Brzenska R, Kiefel V, Hoffmann W. Implications of demographics on future blood supply: a population-based cross-sectional study. Transfusion 2011; 51: 702-709
• 2 Greinacher A, Fendrich K, Alpen U, Hoffmann W. Impact of demographic changes on the blood supply: Mecklenburg-West Pomerania as a model region for Europe. Transfusion 2007; 47: 395-401
• 3 Cobain TJ, Vamvakas EC, Wells A, Titlestad K. A survey of the demographics of blood use. Transfus Med 2007; 17: 1-15
• 4 Guralnik JM, Eisenstaedt RS, Ferrucci L, Klein HG, Woodman RC. Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood 2004; 104: 2263-2268
• 5 Beattie WS, Karkouti K, Wijeysundera DN, Tait G. Risk associated with preoperative anemia in noncardiac surgery: a single-center cohort study. Anesthesiology 2009; 110: 574-581
• 6 Wu WC, Schifftner TL, Henderson WG, Eaton CB, Poses RM, Uttley G et al. Preoperative hematocrit levels and postoperative outcomes in older patients undergoing noncardiac surgery. Jama 2007; 297: 2481-2488
• 7 Bernard AC, Davenport DL, Chang PK, Vaughan TB, Zwischenberger JB. Intraoperative transfusion of 1 U to 2 U packed red blood cells is associated with increased 30-day mortality, surgical-site infection, pneumonia, and sepsis in general surgery patients. J Am Coll Surg. discussion 2009; 208: 938-939
• 8 Murphy GJ, Reeves BC, Rogers CA, Rizvi SI, Culliford L, Angelini GD. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation 2007; 116: 2544-2552
• 9 Spahn DR, Moch H, Hofmann A, Isbister JP. Patient blood management: the pragmatic solution for the problems with blood transfusions. Anesthesiology 2008; 109: 951-953
• 10 Karkouti K, Wijeysundera DN, Beattie WS. Risk associated with preoperative anemia in cardiac surgery: a multicenter cohort study. Circulation 2008; 117: 478-484
• 11 Ranucci M, Conti D, Castelvecchio S, Menicanti L, Frigiola A, Ballotta A et al. Hematocrit on cardiopulmonary bypass and outcome after coronary surgery in nontransfused patients. Ann Thorac Surg 2010; 89: 11-17
• 12 Oliver E, Carrio ML, Rodriguez-Castro D, Javierre C, Farrero E, Torrado H et al. Relationships among haemoglobin level, packed red cell transfusion and clinical outcomes in patients after cardiac surgery. Intensive Care Med 2009; 35: 1548-1555
• 13 Licker M, Sierra J, Kalangos A, Panos A, Diaper J, Ellenberger C. Cardioprotective effects of acute normovolemic hemodilution in patients with severe aortic stenosis undergoing valve replacement. Transfusion 2007; 47: 341-350
• 14 von Heymann C et al. The impact of an hematocrit of 20% during normothermic cardiopulmonary bypass for elective low risk coronary artery bypass graft surgery on oxygen delivery and clinical outcome – a randomized controlled study [ISRCTN35655335]. Crit Care 2006; 10
• 15 Karkouti K et al. The independent association of massive blood loss with mortality in cardiac surgery. Transfusion 2004; 44: 1453-1462
• 16 Engoren MC, Habib RH, Zacharias A, Schwann TA, Riordan CJ, Durham SJ. Effect of blood transfusion on long-term survival after cardiac operation. Ann Thorac Surg 2002; 74: 1180-1186
• 17 Halm EA, Wang JJ, Boockvar K, Penrod J, Silberzweig SB, Magaziner J et al. The effect of perioperative anemia on clinical and functional outcomes in patients with hip fracture. J Orthop Trauma 2004; 18: 369-374
• 18 Conlon NP, Bale EP, Herbison GP, McCarroll M. Postoperative anemia and quality of life after primary hip arthroplasty in patients over 65 years old. Anesth Analg 2008; 106: 1056-1061
• 19 Vuille-Lessard E, Boudreault D, Girard F, Ruel M, Chagnon M, Hardy JF. Postoperative anemia does not impede functional outcome and quality of life early after hip and knee arthroplasties. Transfusion DOI: 10.1111/j.1537-2995.2011.03272.x.. [Epub ahead of print] 2011;
• 20 Hare GM, Baker JE, Pavenski K. Assessment and treatment of preoperative anemia: Continuing Professional Development. Can J Anaesth 2011; 58: 569-581
• 21 Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE et al. ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2007; 116: 1971-1996
• 22 Saleh E, McClelland DB, Hay A, Semple D, Walsh TS. Prevalence of anaemia before major joint arthroplasty and the potential impact of preoperative investigation and correction on perioperative blood transfusions. Br J Anaesth 2007; 99: 801-808
• 23 www.de.statista.com/statistik/daten/studie/161917/umfrage/erstimplantationen---hueftgelenke-und-kniegelenke-seit-2003/
• 24 Freedman J, Luke K, Escobar M, Vernich L, Chiavetta JA. Experience of a network of transfusion coordinators for blood conservation (Ontario Transfusion Coordinators [ONTraC]). Transfusion 2008; 48: 237-250
• 25 Orlov D, O'Farrell R, McCluskey SA, Carroll J, Poonawala H, Hozhabri S et al. The clinical utility of an index of global oxygenation for guiding red blood cell transfusion in cardiac surgery. Transfusion 2009; 49: 682-688
• 26 Tsai AG, Cabrales P, Intaglietta M. Microvascular perfusion upon exchange transfusion with stored red blood cells in normovolemic anemic conditions. Transfusion 2004; 44: 1626-1634
• 27 Raat NJ, Hilarius PM, Johannes T, de KorteD, Ince C, Verhoeven AJ. Rejuvenation of stored human red blood cells reverses the renal microvascular oxygenation deficit in an isovolemic transfusion model in rats. Transfusion 2009; 49: 427-424
• 28 Rogers MA, Blumberg N, Saint S, Langa KM, Nallamothu BK. Hospital variation in transfusion and infection after cardiac surgery: a cohort study. BMC Med 2009; 7: 37-37
• 29 Bierbaum BE, Callaghan JJ, Galante JO, Rubash HE, Tooms RE, Welch RB. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am 1999; 81: 2-10
• 30 Pedersen AB, Mehnert F, Overgaard S, Johnsen SP. Allogeneic blood transfusion and prognosis following total hip replacement: a population-based follow up study. BMC Musculoskelet Disord 2009; 10: 167-167
• 31 Yang X, Alexander KP, Chen AY, Roe MT, Brindis RG, Rao SV et al. The implications of blood transfusions for patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative. J Am Coll Cardiol 2005; 46: 1490-1495
• 32 Hébert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999; 340: 409-417
• 33 Hajjar LA et al. Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. JAMA 2010; 304: 1559-1567
• 34 Lacroix J, Hébert PC, Hutchison JS, Hume HA, Tucci M, Ducruet T, Gauvin F, Collet JP, Toledano BJ, Robillard P, Joffe A, Biarent D, Meert K, Peters MJ. TRIPICU Investigators, Canadian Critical Care Trials Group, Pediatric Acute Lung Injury and Sepsis Investigators Network. Transfusion strategies for patients in pediatric intensive care units. N Engl J Med 2007; 356: 1609-1619
• 35 Wu WC, Rathore SS, Wang Y, Radford MJ, Krumholz HM. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med 2001; 345: 1230-1236
• 36 Shander A, Hofmann A, Ozawa S, Theusinger OM, Gombotz H, Spahn DR. Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion 2010; 50: 753-765
• 37 Bisbe E, Castillo J, Saez M, Santiveri X, Ruiz A, Munoz M. Prevalence of preoperative anemia and hematinic deficiencies in patients scheduled for elective major orthopedic surgery. Transfusion Alternatives in Transfusion Medicine 2009; 10: 166-117
• 38 Goodnough LT et al. Detection, evaluation, and management of preoperative anaemia in the elective orthopaedic surgical patient: NATA guidelines. Br J Anaesth 2011; 106: 13-22
• 39 Gesetz zur Regelung des Transfusionswesens (Transfusionsgesetz – TFG) vom 1. Juli 1998 ausgegeben zu Bonn am 6. Juli 1998 (BGBl.I), S. 1752-1760
• 40 García-Erce JA, Cuenca J, Haman-Alcober S, Martínez AA, Herrera A, Muñoz M. Efficacy of preoperative recombinant human erythropoietin administration for reducing transfusion requirements in patients undergoing surgery for hip fracture repair. An observational cohort study. Vox Sang 2009; 97: 260-267
• 41 Olijhoek G, Megens JG, Musto P, Nogarin L, Gassmann-Mayer C, Vercammen E, Hayes-Licitra SA. Role of oral versus IV iron supplementation in the erythropoietic response to rHuEPO: a randomized, placebo-controlled trial. Transfusion 2001; 41: 957-963
• 42 García-Erce JA, Cuenca J, Muñoz M, Izuel M, Martínez AA, Herrera A, Solano VM, Martínez F. Perioperative stimulation of erythropoiesis with intravenous iron and erythropoietin reduces transfusion requirements in patients with hip fracture. A prospective observational study. Vox Sang 2005; 88: 235-243
• 43 Theusinger OM, Leyvraz PF, Schanz U, Seifert B, Spahn DR. Treatment of iron deficiency anemia in orthopedic surgery with intravenous iron: efficacy and limits: a prospective study. Anesthesiology 2007; 107: 923-927
• 44 Na HS, Shin SY, Hwang JY, Jeon YT, Kim CS, Do SH. Effects of intravenous iron combined with low-dose recombinant human erythropoietin on transfusion requirements in iron-deficient patients undergoing bilateral total knee replacement arthroplasty. Transfusion 2011; 51: 118-124
• 45 Fachinformation Erypo®FS 40.000I.E., Janssen-Cilag GmbH, Stand Januar. 2011
• 46 Rosencher N, Poisson D, Albi A, Aperce M, Barré J, Samama CM. Two injections of erythropoietin correct moderate anemia in most patients awaiting orthopedic surgery. Can J Anaesth 2005; 52: 160-165